These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15806300)

  • 1. Expression of thioredoxin in patients with Graves' disease.
    Kihara M; Kontani K; Yamauchi A; Miyauchi A; Nakamura H; Yodoi J; Yokomise H
    Int J Mol Med; 2005 May; 15(5):795-9. PubMed ID: 15806300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triiodothyronine, thyroxine, and iodine in purified thyroglobulin from patients with Graves' disease.
    Izumi M; Larsen PR
    J Clin Invest; 1977 Jun; 59(6):1105-12. PubMed ID: 577211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of interleukins on EGF-stimulated growth promotion in human thyroid cells: differential modifications by IL-2 and IL-6 in Graves' and normal thyroid cells.
    Shimomura N; Itoh M; Okugawa T; Murata Y; Seo H
    Endocr Regul; 1994 Jun; 28(2):55-65. PubMed ID: 7949016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial hyperplasia and decreased colloid content of the thyroid gland in triiodothyronine-predominant Graves' disease.
    Takamatsu J; Takeda K; Katayama S; Sakane S; Morita S; Kuma K; Ohsawa N
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1145-50. PubMed ID: 1400885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of thyroid cell growth by serum IgG in Graves' disease.
    Itoh M; Shimomura N; Okugawa T
    Horm Metab Res; 1992 Jul; 24(7):319-21. PubMed ID: 1516886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodide, cytokines and TSH-receptor expression in Graves' disease.
    Schuppert F; Hiller W; Weinland G; Hoang-Vu C; von zur Mühlen A; Kohn LD
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():68-74. PubMed ID: 8981006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thioredoxin and thioredoxin reductase expression in thyroid cancer depends on tumour aggressiveness.
    Lincoln DT; Al-Yatama F; Mohammed FM; Al-Banaw AG; Al-Bader M; Burge M; Sinowatz F; Singal PK
    Anticancer Res; 2010 Mar; 30(3):767-75. PubMed ID: 20392995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The thioredoxin-thioredoxin reductase system: over-expression in human cancer.
    Lincoln DT; Ali Emadi EM; Tonissen KF; Clarke FM
    Anticancer Res; 2003; 23(3B):2425-33. PubMed ID: 12894524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A predictive mathematical model for the calculation of the final mass of Graves' disease thyroids treated with 131I.
    Traino AC; Di Martino F; Grosso M; Monzani F; Dardano A; Caraccio N; Mariani G; Lazzeri M
    Phys Med Biol; 2005 May; 50(9):2181-91. PubMed ID: 15843745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of the novel autoantibody (anti-UACA antibody) in patients with Graves' disease.
    Ohkura T; Taniguchi S; Yamada K; Nishio N; Okamura T; Yoshida A; Kamijou K; Fukata S; Kuma K; Inoue Y; Hisatome I; Senju S; Nishimura Y; Shigemasa C
    Biochem Biophys Res Commun; 2004 Aug; 321(2):432-40. PubMed ID: 15358194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spiking expression of mu-crystallin mRNA during treatment with methimazole in patients with graves' hyperthyroidism.
    Suzuki S; Takei M; Nishio S; Inaba H; Sato A; Yamazaki M; Shinomiya K; Hashizume K
    Horm Metab Res; 2009 Jul; 41(7):548-53. PubMed ID: 19280551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcome of Graves' disease in Thai children.
    Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
    J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High redox thioredoxin but low thioredoxin reductase activities in the serum of patients with rheumatoid arthritis.
    Lemarechal H; Allanore Y; Chenevier-Gobeaux C; Ekindjian OG; Kahan A; Borderie D
    Clin Chim Acta; 2006 May; 367(1-2):156-61. PubMed ID: 16458876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
    Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P
    Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid cancer yield in patients with Graves' disease.
    Stocker DJ; Burch HB
    Minerva Endocrinol; 2003 Sep; 28(3):205-12. PubMed ID: 14605602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased production of B-cell growth factor by T lymphocytes in Graves' thyroid: possible role of CD4+ CD29+ cells.
    Goto Y; Itoh M; Ohta Y; Ogawa N; Goto Y; Ohashi H
    Thyroid; 1997 Aug; 7(4):567-73. PubMed ID: 9292944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of apoptotic proteins in thyroid gland from patients with Graves' disease and Hashimoto's thyroiditis.
    Bossowski A; Czarnocka B; Bardadin K; Stasiak-Barmuta A; Urban M; Dadan J; Ratomski K; Bossowska A
    Autoimmunity; 2008 Mar; 41(2):163-73. PubMed ID: 18324486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of additional inactive iodide during radioiodine therapy for Graves' disease: who might benefit?
    Dietlein M; Moka D; Reinholz U; Schmidt M; Schomäcker K; Schicha H; Wellner U
    Nuklearmedizin; 2007; 46(3):77-84. PubMed ID: 17549318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of lymphocytes and thyrocytes in Graves' disease and nonautoimmune thyroid diseases in immunohistochemical and ultrastructural investigations.
    Ben-Skowronek I; Sierocinska-Sawa J; Szewczyk L; Korobowicz E
    Horm Res; 2009; 71(6):350-8. PubMed ID: 19506393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Bcl-2 family proteins in thyrocytes from young patients with immune and nonimmune thyroid diseases.
    Bossowski A; Czarnocka B; Bardadin K; Urban M; Niedziela M; Dadan J
    Horm Res; 2008; 70(3):155-64. PubMed ID: 18663316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.